Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Increased epigenetic age in normal breast tissue from luminal breast cancer patients

Open access

Abstract

BACKGROUND: Age is one of the most important risk factors for developing breast cancer. However, age-related changes in normal breast tissue that potentially lead to breast cancer are incompletely understood. Quantifying tissue-level DNA methylation can contribute to understanding these processes. We hypothesized that occurrence of breast cancer should be associated with an acceleration of epigenetic aging in normal breast tissue. RESULTS: Ninety-six normal breast tissue samples were obtained from 88 subjects (breast cancer = 35 subjects/40 samples, unaffected = 53 subjects/53 samples). Normal tissue samples from breast cancer patients were obtained from distant non-tumor sites of primary mastectomy specimens, while samples from unaffected women were obtained from the Komen Tissue Bank (n = 25) and from non-cancer-related breast surgery specimens (n = 28). Patients were further stratified into four cohorts: age < 50 years with and without breast cancer and age ≥ 50 with and without breast cancer. The Illumina HumanMethylation450k BeadChip microarray was used to generate methylation profiles from extracted DNA samples. Data was analyzed using the "Epigenetic Clock," a published biomarker of aging based on a defined set of 353 CpGs in the human genome. The resulting age estimate, DNA methylation age, was related to chronological age and to breast cancer status. The DNAmAge of normal breast tissue was strongly correlated with chronological age (r = 0.712, p < 0.001). Compared to unaffected peers, breast cancer patients exhibited significant age acceleration in their normal breast tissue (p = 0.002). Multivariate analysis revealed that epigenetic age acceleration in the normal breast tissue of subjects with cancer remained significant after adjusting for clinical and demographic variables. Additionally, smoking was found to be positively correlated with epigenetic aging in normal breast tissue (p = 0.012). CONCLUSIONS: Women with luminal breast cancer exhibit significant epigenetic age acceleration in normal adjacent breast tissue, which is consistent with an analogous finding in malignant breast tissue. Smoking is also associated with epigenetic age acceleration in normal breast tissue. Further studies are needed to determine whether epigenetic age acceleration in normal breast tissue is predictive of incident breast cancer and whether this mediates the risk of chronological age on breast cancer risk.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13148-018-0534-8

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Tissue epigenetic age versus chronological age. DNA methylation age estimate based on 353 CpGs (y-axis) versus chronological age. All samples are normal breast tissue samples; normal tissue samples from cancer patients were obtained from mastectomy specimens > 3 cm from tumor margin. Samples (points) are colored by disease status of the donor: red = breast cancer and green = control. A linear regression line has been added. Age acceleration is defined as raw residual resulting from the regression model, i.e., the (signed) vertical distance to the line. Points above and below the line exhibit positive and negative epigenetic age acceleration, respectively. The high Pearson correlation coefficient r = 0.712, (p < 0.001) reflects the strong linear relationship between DNAmAge and chronological age at the time of breast sample collection
Fig. 1 Tissue epigenetic age versus chronological age. DNA methylation age estimate based on 353 CpGs (y-axis) versus chronological age. All samples are normal breast tissue samples; normal tissue samples from cancer patients were obtained from mastectomy specimens > 3 cm from tumor margin. Samples (points) are colored by disease status of the donor: red = breast cancer and green = control. A linear regression line has been added. Age acceleration is defined as raw residual resulting from the regression model, i.e., the (signed) vertical distance to the line. Points above and below the line exhibit positive and negative epigenetic age acceleration, respectively. The high Pearson correlation coefficient r = 0.712, (p < 0.001) reflects the strong linear relationship between DNAmAge and chronological age at the time of breast sample collectionCC BY · PubMed Central
Fig. 2 Comparison of epigenetic variables between cases and controls. Bar plots depict mean epigenetic age and age acceleration (y-axis) versus disease status. a Mean methylation levels of each cohort. b DNAmAge of each cohort. c Age acceleration differences. d Age acceleration residuals. The cancer cohort exhibits a significant positive age acceleration (positive residual coefficient) correlation compared to controls
Fig. 2 Comparison of epigenetic variables between cases and controls. Bar plots depict mean epigenetic age and age acceleration (y-axis) versus disease status. a Mean methylation levels of each cohort. b DNAmAge of each cohort. c Age acceleration differences. d Age acceleration residuals. The cancer cohort exhibits a significant positive age acceleration (positive residual coefficient) correlation compared to controlsCC BY · PubMed Central
Fig. 3 Correlation of tobacco use variables between cases and controls. DNA methylation age acceleration estimates (y-axis) are depicted for specific tobacco use variables, including total pack years, total number of years smoking, and cigarettes per day. a–c Analyses for these variables using the combination of both study cohorts. d–f The same specific variable analyses for the control cohort. g–i Analyses for the cancer cohort. There is a statistically significant positive correlation between the tobacco variables and the complete cohort, and in the control cases. Though a positive correlation is noted in breast cancer cases as well, it did not reach a statistical significance
Fig. 3 Correlation of tobacco use variables between cases and controls. DNA methylation age acceleration estimates (y-axis) are depicted for specific tobacco use variables, including total pack years, total number of years smoking, and cigarettes per day. a–c Analyses for these variables using the combination of both study cohorts. d–f The same specific variable analyses for the control cohort. g–i Analyses for the cancer cohort. There is a statistically significant positive correlation between the tobacco variables and the complete cohort, and in the control cases. Though a positive correlation is noted in breast cancer cases as well, it did not reach a statistical significanceCC BY · PubMed Central
Fig. 4 Receiver operating characteristic for all epigenetic variables. Receiver operating characteristic (ROC) were plotted for breast cancer status as the reference variable and age, DNAmAge, mean methylation by sample, age acceleration difference, and age acceleration residuals as classification variables. DeLong method was used to calculate the standard errors, and binomial confidence intervals were calculated. The ROC curves were plotted based on the binomial fit models, and the AUC was calculated. The sensitivity and specificity of the most predictive epigenetic variable was then calculated based on the ROC curve
Fig. 4 Receiver operating characteristic for all epigenetic variables. Receiver operating characteristic (ROC) were plotted for breast cancer status as the reference variable and age, DNAmAge, mean methylation by sample, age acceleration difference, and age acceleration residuals as classification variables. DeLong method was used to calculate the standard errors, and binomial confidence intervals were calculated. The ROC curves were plotted based on the binomial fit models, and the AUC was calculated. The sensitivity and specificity of the most predictive epigenetic variable was then calculated based on the ROC curveCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 64

Metadata

Authors
Hofstatter, E. W., Horvath, S., Dalela, D., Gupta, P., Chagpar, A. B., Wali, V. B., Bossuyt, V., Storniolo, A. M., Hatzis, C., Patwardhan, G., Von Wahlde, M.-K., Butler, M., Epstein, L., Stavris, K., Sturrock, T., Au, A., Kwei, S., & Pusztai, L.
Affiliations
  • Yale University (US)
  • University of California, Los Angeles (US)
  • Memorial Sloan Kettering Cancer Center (US)
  • Indiana University Health (US)
Corresponding author
Hofstatter, Erin W.
Venue
Clinical Epigenetics
Published
2018-08-29
Volume
10
Issue
1
Pages
112-112
ISSN
  • 1868-7075 (ISSN-L)
  • 1868-7083
OpenAlex
W2889199419
Cited by
64
References
19
Citations by year
2026: 6 · 2025: 8 · 2024: 4 · 2023: 8 · 2022: 6 · 2021: 17 · 2020: 9 · 2019: 6
FWCI
2.84
Type
journal article
Language
en
Open access
Licence
Locations
  • Clinical Epigenetics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • IUScholarWorks (Indiana University) (submittedVersion, cc-by-nc-nd)
Funders
  • Terri Brodeur Breast Cancer Foundation
  • Lion Heart Foundation
  • National Cancer Institute (P30-CCITLA)
  • National Institute on Aging (5R01AG042511-02, U34AG051425-01)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
epigenetic age acceleration, DNA methylation, luminal breast cancer, normal breast tissue, epigenetic clocks, smoking, breast cancer risk, chronological age, cancer risk biomarkers
MeSH terms
Adult, Age Factors, Breast, Breast Neoplasms, Female, Humans, Middle Aged, Tissue Banks, Case-Control Studies, Sequence Analysis, DNA, CpG Islands, DNA Methylation, Epigenesis, Genetic, High-Throughput Nucleotide Sequencing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased epigenetic age in normal breast tissue from luminal breast cancer patients. https://app.cochat.ai/papers/10.1186/s13148-018-0534-8
The paper
Hofstatter, E. W., Horvath, S., Dalela, D., Gupta, P., Chagpar, A. B., Wali, V. B., Bossuyt, V., Storniolo, A. M., Hatzis, C., Patwardhan, G., Von Wahlde, M.-K., Butler, M., Epstein, L., Stavris, K., Sturrock, T., Au, A., Kwei, S., & Pusztai, L. (2018). Increased epigenetic age in normal breast tissue from luminal breast cancer patients. Clinical Epigenetics. https://doi.org/10.1186/s13148-018-0534-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.